Shum Yip Capital
Overview
Shum Yip Capital is the private equity investment and management subsidiary of Shenzhen Investment Holdings Co., Ltd. (SIHC), a major state-owned enterprise in Shenzhen. The firm focuses on strategic investments in emerging technology sectors such as information technology, biomedicine, and advanced manufacturing, primarily within the Greater Bay Area.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Hexaell Biotech Co., Ltd. | Apr 2026 | Series B++ | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Shum Yip Capital based?
Shum Yip Capital is headquartered in Shenzhen, China.
When was Shum Yip Capital founded?
Shum Yip Capital was founded in 2016.
How many portfolio companies does Shum Yip Capital have?
Shum Yip Capital has 3 portfolio companies in Caplight's dataset.
What are some companies in Shum Yip Capital's portfolio?
Portfolio companies visible on Caplight include Hexaell Biotech Co., Ltd..
What was Shum Yip Capital's most recent investment shown here?
Shum Yip Capital's most recent investment in this portfolio sample was in Hexaell Biotech Co., Ltd. in 2026.
What sectors does Shum Yip Capital focus on?
Shum Yip Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Shum Yip Capital focus on?
Shum Yip Capital typically invests at the Mid stage.
What is Shum Yip Capital's AUM?
Shum Yip Capital's assets under management are estimated at over $8.3B.